Christopher M. Starr - Director at Monopar Therapeutics

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
MNPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher M. Starr since 12/23/2023

Holdings reported by Christopher M. Starr for Monopar Therapeutics

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 49.4K $16.8K $0.34 Dec 31, 2023 Indirect
Common Stock 25.9K $8.8K $0.34 Dec 31, 2023 Direct
Restricted Stock Units 0 $0.34 Dec 31, 2023 Direct Common Stock

Transactions reported by Christopher M. Starr for Monopar Therapeutics

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.